Christopher Keating

FDA investigator · also recorded as Seas Christopher Keating, Cal Christopher Keating

Appears on 13 documents from 2018 to 2020, mostly at sites in India. Most often cites production record review (21 CFR 211.192).

13
Documents on file
5.5
Observations per 483
2018
First seen
2020
Most recent

What they cite most

From 61 observations

Activity by year

2018: 5, 2019: 6, 2020: 2

Where

India 7 · China 2 · France 1 · Germany 1 · Italy 1 · North Carolina 1

Is Christopher Keating coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Dr. Reddy's Laboratories Ltd. - CTO 5Mar 5, 2020 · Nalgonda, India
483 Matrix Pharmacorp Private LimitedFeb 28, 2020 · Patancheru, India
483 Recipharm MontsNov 12, 2019 · Monts, France
483 CIPLA LIMITEDJul 19, 2019 · Bengaluru, India
483 Dr. Reddy's Laboratories Limited (Unit II)Jul 12, 2019 · Bollaram, India
483 Symbiotec Pharmalab Private LimitedJul 5, 2019 · Pithampur, India
483 Jilin Asymchem Laboratories Co., Ltd.Apr 12, 2019 · Dunhua, China

About this profile

What does Christopher Keating inspect?

Christopher Keating appears on 13 documents on file covering 12 sites, mostly in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.67 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Christopher Keating is dated Mar 5, 2020.